Affitech Appoints Dr Robert Burns as CEO and Dr Alexander Duncan as SVP Research & Development
02-Sep-2009 -
Affitech A/S announced that it has appointed two experienced biotech executives to head its management team. Dr Robert Burns, previously CEO of Celldex Therapeutics Inc., has assumed overall responsibility for Affitech as its new Chief Executive Officer. Dr Alexander Duncan, previously SVP ...
AstraZeneca
blood coagulation
Brazil
+11